Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.
Full Article
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?
NYTimes.com
0 shares
1 views
You might like
Related news coverage
WHO: ‘Vaccine Inequity . . . Demonstrates a Disregard for the World’s Poorest’
VOA News
The World Health Organization has written an open letter to the heads of state gathered in Rome for the G-20 meeting, urging them..
-
G-20 leaders to tackle energy prices, other economic woes
SeattlePI.com
-
WHO Chief: World’s Wealthy Nations Can End COVID-19 Pandemic Now
VOA News
-
Africa: New Act-Accelerator Strategy Calls for U.S.$ 23.4 Billion to Solve Inequities in Access to Covid-19 Vaccines, Tests & Treatments
allAfrica.com
-
The Inside Story-Fighting the Pandemic TRANSCRIPT
VOA News
Advertisement
More coverage
Africa: Calls for International Investment to Solve Inequities in Global Access to Covid-19 Vaccines, Tests and Treatments
allAfrica.com
[WHO] Geneva -- New ACT-Accelerator strategic plan sets out urgent actions to address crucial gaps in access to COVID-19 tests,..